The outcome of the US presidential election in November, whether Democrat president Joe Biden wins the election or former Republican president Donald Trump, is bound to result in continued emphasis on drug prices and health care spending.
The Looming US Election Weighs On The Minds Of Pharma
The US presidential election in November could mean IRA expansion from a Biden win, but a Trump victory also brings uncertainty.
